Back to results
US 12,699,096 B2Granted
Method of detecting lung cancer
AssigneeBioMark Cancer Systems Inc.
InventorsRashid Bux, Daniel Sitar
Life of this patent
Estimating the term…
Abstract
A biomarker panel and method for a urine test for detecting lung cancer detects a biomarker selected from the group of biomarkers consisting of DMA, C5:1, C10:1, ADMA, C5-OH, SDMA, and kynurenine, or a combination thereof.
Claims12
A method for processing a human clinical urine sample, the method comprising obtaining a urine sample from a subject clinically assessed as having or suspected of having lung cancer, and quantifying a panel of metabolites in said urine sample, the panel comprising at least one urinary metabolite selected from C5:1, C10:1, ADMA, C5-OH, and SDMA.
Dependencies are inferred from the claim text.